Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

TTK HEALTHCARE Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.7413.438.0324.0616.71

What is the latest EV/Core EBITDA ratio of TTK HEALTHCARE ?

The latest EV/Core EBITDA ratio of TTK HEALTHCARE is 8.74 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20258.74
Mar202413.43
Mar20238.03
Mar202224.06
Mar202116.71

How is EV/Core EBITDA of TTK HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2025 8.74
-34.92
Mar2024 13.43
67.25
Mar2023 8.03
-66.63
Mar2022 24.06
43.99
Mar2021 16.71 -

Other Financial Ratios of TTK HEALTHCARE


Compare EV/Core EBITDA ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,256.4 Cr 13.9% 3.1% -31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,150.0 Cr -0.9% -3.9% 1.3% Stock Analytics
DIVIS LABORATORIES ₹156,129.0 Cr -0.4% -7.6% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,312.0 Cr -2% -7.5% 27.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,445.2 Cr -1.5% -9.3% 3.8% Stock Analytics
CIPLA ₹98,210.2 Cr 1.7% -8.3% -16.8% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

13.9%

3.1%

-31.8%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses